Category:natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Boiling Point: | 476.10 °C. @ 760.00 mm Hg (est)
|
Flash Point: | 417.00 °F. TCC ( 214.10 °C. ) (est)
|
logP (o/w): | 1.810 (est) |
Soluble in: |
| water, 582 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intraperitoneal-dog LD50 > 200 mg/kg BEHAVIORAL: MUSCLE WEAKNESS
GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) Archives Internationales de Pharmacodynamie et de Therapie. Vol. 138, Pg. 505, 1962.
intraperitoneal-mouse LD50 420 mg/kg Experientia. Vol. 26, Pg. 283, 1970.
oral-mouse LD50 1050 mg/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: ATAXIA
BEHAVIORAL: MUSCLE WEAKNESS Archives Internationales de Pharmacodynamie et de Therapie. Vol. 138, Pg. 505, 1962.
intraperitoneal-rabbit LD50 300 mg/kg GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) Archives Internationales de Pharmacodynamie et de Therapie. Vol. 138, Pg. 505, 1962.
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | natural substances and extractives |
Recommendation for dihydromethysticin usage levels up to: | | not for fragrance use.
|
|
Recommendation for dihydromethysticin flavor usage levels up to: |
| not for flavor use.
|
Safety References:
EPI System: View |
Chemical Carcinogenesis Research Information System:Search |
AIDS Citations:Search |
Cancer Citations:Search |
Toxicology Citations:Search |
EPA ACToR:Toxicology Data |
EPA Substance Registry Services (SRS):Registry |
Laboratory Chemical Safety Summary :88308 |
National Institute of Allergy and Infectious Diseases:Data |
(2S)-2-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-2,3-dihydropyran-6-one |
Chemidplus:0019902911 |
References:
| (2S)-2-[2-(1,3-benzodioxol-5-yl)ethyl]-4-methoxy-2,3-dihydropyran-6-one |
NIST Chemistry WebBook: | Search Inchi |
Pubchem (cid): | 88308 |
Pubchem (sid): | 135046882 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
(S)-6-(2-(1,3- | benzodioxol-5-yl)ethyl)-5,6-dihydro-4-methoxy-2H-pyran-2-one | (2S)-2-[2-(1,3- | benzodioxol-5-yl)ethyl]-4-methoxy-2,3-dihydropyran-6-one | (6S)-6-[2-(1,3- | benzodioxol-5-yl)ethyl]-4-methoxy-5,6-dihydro-2H-pyran-2-one | 7,8- | dihydromethysticin | | methysticin, 7,8-dihydro- | 2H- | pyran-2-one, 5,6-dihydro-4-methoxy-6-(3,4-(methylenedioxy)phenethyl)-, (S)- | 2H- | pyran-2-one, 6-(2-(1,3-benzodioxol-5-yl)ethyl)-5,6-dihydro-4-methoxy-, (S)- (9CI) | 2H- | pyran-2-one, 6-[2-(1,3-benzodioxol-5-yl)ethyl]-5,6-dihydro-4-methoxy-, (6S)- |
Articles:
PubMed:Phototoxicity of kava - formation of reactive oxygen species leading to lipid peroxidation and DNA damage. |
PubMed:Kavalactone metabolism in rat liver microsomes. |
PubMed:Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells. |
PubMed:Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1. |
PubMed:Proposal for a kava quality standardization code. |
PubMed:Herbal bioactivation, molecular targets and the toxicity relevance. |
PubMed:Highly regio- and stereoselective Heck reaction of allylic esters with arenediazonium salts: application to the synthesis of kavalactones. |
PubMed:Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. |
PubMed:Permeability studies of Kavalactones using a Caco-2 cell monolayer model. |
PubMed:Fourier transform ion cyclotron resonance mass spectrometry for the characterisation of kavalactones in the kava plant: elemental formulae confirmation by dual spray accurate mass measurement and structural confirmation by infrared multiphoton dissociation and sustained off-resonance irradiation collision induced dissociation. |
PubMed:Herbicidal and Fungicidal Activities of Lactones in Kava (Piper methysticum). |
PubMed:Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. |
PubMed:Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro. |
PubMed:Determination of kava lactones in food supplements by liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry. |
PubMed:Determination of six kavalactones in dietary supplements and selected functional foods containing Piper methysticum by isocratic liquid chromatography with internal standard. |
PubMed:LC-UV and LC-MS analysis of food and drink products containing kava. |
PubMed:Antimycobacterial compounds from Piper sanctum. |
PubMed:Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. |
PubMed:In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. |
PubMed:Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava). |
PubMed:Inhibition of human cytochrome P450 activities by kava extract and kavalactones. |
PubMed:Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. |
PubMed:Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. |
PubMed:Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review. |
PubMed:Interaction of various Piper methysticum cultivars with CNS receptors in vitro. |
PubMed:Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. |
PubMed:Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). |
PubMed:Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. |
PubMed:Influence of genuine kavapyrone enantiomers on the GABA-A binding site. |
PubMed:In vivo effects of the kavapyrones (+)-dihydromethysticin and (+/-)-kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions. |
PubMed:Kavain, dihydrokavain, and dihydromethysticin non-competitively inhibit the specific binding of [3H]-batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated Na+ channels. |
PubMed:Contribution to the quantitative and enantioselective determination of kavapyrones by high-performance liquid chromatography on ChiraSpher NT material. |
PubMed:Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs. |
PubMed:Effects of kawain and dihydromethysticin on field potential changes in the hippocampus. |
PubMed:Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract. |
PubMed:Piper methysticum: enantiomeric separation of kavapyrones by high performance liquid chromatography. |
PubMed:Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. |
PubMed:The antinociceptive actions of kava components in mice. |
PubMed:[Spasmolytic effect of dihydromethysticin, a constituent of Piper methysticum Forst]. |
PubMed:[A STUDY OF THE ANTICONVULSANT PROPERTIES OF THE KAWA PYRONES DIHYDROMETHYSTICIN (DHM) AND DIHYROKAWAIN (DHK) IN CHEMICALLY INDUCED CONCLUSIONS]. |
PubMed:[INHIBITION OF ELECTROCONVULSION BY THE KAVA-PYRONES DIHYDROMETHYSTICIN AND DIHYDROKAVAIN]. |
|